Jerome Bressi, Ph.D., is Senior Vice President of Regulatory & Quality at Fate Therapeutics, overseeing all aspects of regulatory, quality assurance, and quality control functions related to clinical development, CMC, and future commercialization. Previously, Dr. Bressi held the positions of Vice President of Regulatory Affairs & Quality Assurance and Executive Director of Regulatory Affairs at Fate Therapeutics. Prior to joining Fate, he served as President of BioPharma Regulatory Solutions where he worked with Janssen Research & Development as a Dossier Development and Operations Lead for the TREMFYA™ (guselkumab) BLA, MAA, and NDS, as well as sBLA for TREMFYA™ One-Press patient-controlled injector. Dr. Bressi also held key regulatory positions at Hyperion Therapeutics and Mast Therapeutics and has more than 25 years of biotechnology and pharmaceutical industry experience in drug discovery and development within oncology, autoimmune, and inherited genetic disorder therapeutic arenas. Dr. Bressi received his Ph.D. from the Department of Chemistry at the University of Washington and his B.S. from the Department of Chemistry at the University of California, San Diego.